ENOVIS CORP (ENOV) Stock Fundamental Analysis

NYSE:ENOV • US1940141062

25.47 USD
+0.05 (+0.2%)
At close: Feb 27, 2026
25.47 USD
0 (0%)
After Hours: 2/27/2026, 8:04:00 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News
Fundamental Rating

4

We assign a fundamental rating of 4 out of 10 to ENOV. ENOV was compared to 184 industry peers in the Health Care Equipment & Supplies industry. ENOV has a bad profitability rating. Also its financial health evaluation is rather negative. ENOV may be a bit undervalued, certainly considering the very reasonable score on growth


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

  • ENOV had positive earnings in the past year.
  • In the past year ENOV had a positive cash flow from operations.
  • ENOV had negative earnings in 4 of the past 5 years.
  • ENOV had a positive operating cash flow in 4 of the past 5 years.
ENOV Yearly Net Income VS EBIT VS OCF VS FCFENOV Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -500M -1B

1.2 Ratios

  • Looking at the Return On Assets, with a value of -30.89%, ENOV is in line with its industry, outperforming 41.62% of the companies in the same industry.
  • ENOV has a Return On Equity of -79.51%. This is comparable to the rest of the industry: ENOV outperforms 42.16% of its industry peers.
Industry RankSector Rank
ROA -30.89%
ROE -79.51%
ROIC N/A
ROA(3y)-16.37%
ROA(5y)-9.72%
ROE(3y)-37.57%
ROE(5y)-22.31%
ROIC(3y)N/A
ROIC(5y)N/A
ENOV Yearly ROA, ROE, ROICENOV Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -20 -40 -60

1.3 Margins

  • With a Gross Margin value of 57.88%, ENOV perfoms like the industry average, outperforming 59.46% of the companies in the same industry.
  • ENOV's Gross Margin has improved in the last couple of years.
  • ENOV does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 57.88%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.23%
GM growth 5Y6.51%
ENOV Yearly Profit, Operating, Gross MarginsENOV Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 -20 40 -40

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

3

2. Health

2.1 Basic Checks

  • ENOV does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • The number of shares outstanding for ENOV has been increased compared to 1 year ago.
  • The number of shares outstanding for ENOV has been increased compared to 5 years ago.
  • The debt/assets ratio for ENOV is higher compared to a year ago.
ENOV Yearly Shares OutstandingENOV Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M 40M 50M
ENOV Yearly Total Debt VS Total AssetsENOV Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B 8B

2.2 Solvency

  • Based on the Altman-Z score of 0.60, we must say that ENOV is in the distress zone and has some risk of bankruptcy.
  • ENOV has a Altman-Z score of 0.60. This is comparable to the rest of the industry: ENOV outperforms 49.19% of its industry peers.
  • The Debt to FCF ratio of ENOV is 65.11, which is on the high side as it means it would take ENOV, 65.11 years of fcf income to pay off all of its debts.
  • Looking at the Debt to FCF ratio, with a value of 65.11, ENOV is in the better half of the industry, outperforming 67.03% of the companies in the same industry.
  • A Debt/Equity ratio of 0.85 indicates that ENOV is somewhat dependend on debt financing.
  • ENOV has a worse Debt to Equity ratio (0.85) than 71.89% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.85
Debt/FCF 65.11
Altman-Z 0.6
ROIC/WACCN/A
WACC9.34%
ENOV Yearly LT Debt VS Equity VS FCFENOV Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 1B 2B 3B 4B

2.3 Liquidity

  • ENOV has a Current Ratio of 2.02. This indicates that ENOV is financially healthy and has no problem in meeting its short term obligations.
  • ENOV has a worse Current ratio (2.02) than 60.54% of its industry peers.
  • A Quick Ratio of 1.04 indicates that ENOV should not have too much problems paying its short term obligations.
  • The Quick ratio of ENOV (1.04) is worse than 76.22% of its industry peers.
Industry RankSector Rank
Current Ratio 2.02
Quick Ratio 1.04
ENOV Yearly Current Assets VS Current LiabilitesENOV Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B 2B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

5

3. Growth

3.1 Past

  • ENOV shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 16.61%, which is quite good.
  • ENOV shows a decrease in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -4.57% yearly.
  • Looking at the last year, ENOV shows a small growth in Revenue. The Revenue has grown by 6.66% in the last year.
  • Measured over the past years, ENOV shows a decrease in Revenue. The Revenue has been decreasing by -6.05% on average per year.
EPS 1Y (TTM)16.61%
EPS 3Y13.28%
EPS 5Y-4.57%
EPS Q2Q%-3.06%
Revenue 1Y (TTM)6.66%
Revenue growth 3Y12.88%
Revenue growth 5Y-6.05%
Sales Q2Q%2.64%

3.2 Future

  • Based on estimates for the next years, ENOV will show a very strong growth in Earnings Per Share. The EPS will grow by 25.47% on average per year.
  • The Revenue is expected to grow by 9.39% on average over the next years. This is quite good.
EPS Next Y6.03%
EPS Next 2Y9.23%
EPS Next 3Y25.47%
EPS Next 5YN/A
Revenue Next Year4.69%
Revenue Next 2Y5.37%
Revenue Next 3Y9.39%
Revenue Next 5YN/A

3.3 Evolution

  • The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
  • The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
ENOV Yearly Revenue VS EstimatesENOV Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 1B 2B 3B 4B
ENOV Yearly EPS VS EstimatesENOV Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2 4 6

More info and screens

Find the best growth stocksShow best growing peers

8

4. Valuation

4.1 Price/Earnings Ratio

  • ENOV is valuated cheaply with a Price/Earnings ratio of 7.72.
  • Based on the Price/Earnings ratio, ENOV is valued cheaper than 98.38% of the companies in the same industry.
  • ENOV is valuated cheaply when we compare the Price/Earnings ratio to 27.07, which is the current average of the S&P500 Index.
  • With a Price/Forward Earnings ratio of 7.28, the valuation of ENOV can be described as very cheap.
  • Compared to the rest of the industry, the Price/Forward Earnings ratio of ENOV indicates a rather cheap valuation: ENOV is cheaper than 98.38% of the companies listed in the same industry.
  • ENOV is valuated cheaply when we compare the Price/Forward Earnings ratio to 28.05, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 7.72
Fwd PE 7.28
ENOV Price Earnings VS Forward Price EarningsENOV Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

  • 92.97% of the companies in the same industry are more expensive than ENOV, based on the Enterprise Value to EBITDA ratio.
  • Compared to the rest of the industry, the Price/Free Cash Flow ratio of ENOV indicates a somewhat cheap valuation: ENOV is cheaper than 69.73% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 73.14
EV/EBITDA 9.65
ENOV Per share dataENOV EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20 30

4.3 Compensation for Growth

  • ENOV's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
  • A more expensive valuation may be justified as ENOV's earnings are expected to grow with 25.47% in the coming years.
PEG (NY)1.28
PEG (5Y)N/A
EPS Next 2Y9.23%
EPS Next 3Y25.47%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. Dividend

5.1 Amount

  • No dividends for ENOV!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

ENOVIS CORP

NYSE:ENOV (2/27/2026, 8:04:00 PM)

After market: 25.47 0 (0%)

25.47

+0.05 (+0.2%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)02-26
Earnings (Next)05-06
Inst Owners117.36%
Inst Owner Change0.03%
Ins Owners1.14%
Ins Owner Change0.32%
Market Cap1.46B
Revenue(TTM)2.25B
Net Income(TTM)-1.18B
Analysts84.44
Price Target46.36 (82.02%)
Short Float %15.5%
Short Ratio8.54
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)13.33%
Min EPS beat(2)13.32%
Max EPS beat(2)13.35%
EPS beat(4)4
Avg EPS beat(4)10.31%
Min EPS beat(4)6.8%
Max EPS beat(4)13.35%
EPS beat(8)8
Avg EPS beat(8)8.3%
EPS beat(12)12
Avg EPS beat(12)8.63%
EPS beat(16)16
Avg EPS beat(16)9.44%
Revenue beat(2)0
Avg Revenue beat(2)-1.7%
Min Revenue beat(2)-3.32%
Max Revenue beat(2)-0.09%
Revenue beat(4)0
Avg Revenue beat(4)-1.4%
Min Revenue beat(4)-3.32%
Max Revenue beat(4)-0.09%
Revenue beat(8)1
Avg Revenue beat(8)-1.24%
Revenue beat(12)4
Avg Revenue beat(12)-0.78%
Revenue beat(16)5
Avg Revenue beat(16)-1.09%
PT rev (1m)0%
PT rev (3m)-9.09%
EPS NQ rev (1m)1.17%
EPS NQ rev (3m)1.34%
EPS NY rev (1m)0.05%
EPS NY rev (3m)-2.1%
Revenue NQ rev (1m)0.37%
Revenue NQ rev (3m)0.42%
Revenue NY rev (1m)0.04%
Revenue NY rev (3m)-1.55%
Valuation
Industry RankSector Rank
PE 7.72
Fwd PE 7.28
P/S 0.65
P/FCF 73.14
P/OCF 6.7
P/B 0.98
P/tB N/A
EV/EBITDA 9.65
EPS(TTM)3.3
EY12.96%
EPS(NY)3.5
Fwd EY13.74%
FCF(TTM)0.35
FCFY1.37%
OCF(TTM)3.8
OCFY14.92%
SpS39.31
BVpS26.05
TBVpS-8.14
PEG (NY)1.28
PEG (5Y)N/A
Graham Number43.98
Profitability
Industry RankSector Rank
ROA -30.89%
ROE -79.51%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 57.88%
FCFM 0.89%
ROA(3y)-16.37%
ROA(5y)-9.72%
ROE(3y)-37.57%
ROE(5y)-22.31%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.23%
GM growth 5Y6.51%
F-Score4
Asset Turnover0.59
Health
Industry RankSector Rank
Debt/Equity 0.85
Debt/FCF 65.11
Debt/EBITDA 4.48
Cap/Depr 67.05%
Cap/Sales 8.78%
Interest Coverage N/A
Cash Conversion 77.17%
Profit Quality N/A
Current Ratio 2.02
Quick Ratio 1.04
Altman-Z 0.6
F-Score4
WACC9.34%
ROIC/WACCN/A
Cap/Depr(3y)62.27%
Cap/Depr(5y)54.89%
Cap/Sales(3y)8.17%
Cap/Sales(5y)7.71%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)16.61%
EPS 3Y13.28%
EPS 5Y-4.57%
EPS Q2Q%-3.06%
EPS Next Y6.03%
EPS Next 2Y9.23%
EPS Next 3Y25.47%
EPS Next 5YN/A
Revenue 1Y (TTM)6.66%
Revenue growth 3Y12.88%
Revenue growth 5Y-6.05%
Sales Q2Q%2.64%
Revenue Next Year4.69%
Revenue Next 2Y5.37%
Revenue Next 3Y9.39%
Revenue Next 5YN/A
EBIT growth 1Y-204.61%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year54.81%
EBIT Next 3Y29.66%
EBIT Next 5YN/A
FCF growth 1Y129.63%
FCF growth 3YN/A
FCF growth 5Y-36.11%
OCF growth 1Y91.44%
OCF growth 3YN/A
OCF growth 5Y-6.37%

ENOVIS CORP / ENOV FAQ

What is the ChartMill fundamental rating of ENOVIS CORP (ENOV) stock?

ChartMill assigns a fundamental rating of 4 / 10 to ENOV.


What is the valuation status of ENOVIS CORP (ENOV) stock?

ChartMill assigns a valuation rating of 8 / 10 to ENOVIS CORP (ENOV). This can be considered as Undervalued.


Can you provide the profitability details for ENOVIS CORP?

ENOVIS CORP (ENOV) has a profitability rating of 2 / 10.


What is the earnings growth outlook for ENOVIS CORP?

The Earnings per Share (EPS) of ENOVIS CORP (ENOV) is expected to grow by 6.03% in the next year.